首页> 美国卫生研究院文献>Stem Cell Research Therapy >Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto’s thyroiditis
【2h】

Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto’s thyroiditis

机译:人角膜缘成纤维细胞样干细胞诱导桥本甲状腺炎女性患者自身反应性T淋巴细胞的免疫耐受

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDue to their “natural immune privilege” and immunoregulatory properties human fibroblast-like limbal stem cells (f-LSCs) have acquired great interest as a potential tool for achieving immunotolerance. Hashimoto’s thyroiditis (HT) is the most common thyroid autoimmune disease and cause of hypothyroidism. To date, conventional hormone replacement therapy and unspecific immunosuppressive regimens cannot provide a definitive cure for HT subjects. We explored the immunosuppressant potential of human f-LSCs on circulating lymphomonocytes (PBMCs) collected from healthy donors and female HT patients.
机译:背景技术由于人类成纤维样角膜缘干细胞(f-LSC)具有“天然免疫特权”和免疫调节特性,因此作为获得免疫耐受的潜在工具已引起了极大的兴趣。桥本氏甲状腺炎(HT)是最常见的甲状腺自身免疫性疾病,是甲状腺功能减退的原因。迄今为止,常规激素替代疗法和非特异性免疫抑制方案尚不能为HT受试者提供明确的治疗方法。我们探讨了人类f-LSC对从健康供体和女性HT患者收集的循环淋巴细胞(PBMC)的免疫抑制潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号